药品注册申请号:065155
申请类型:ANDA (仿制药申请)
申请人:TEVA
申请人全名:TEVA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG No No AB 2005/05/31 2005/05/31 Discontinued
002 CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG No No AB 2005/05/31 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/08/16 SUPPL-21(补充) Approval Labeling STANDARD
2023/07/10 SUPPL-20(补充) Approval Labeling STANDARD
2023/07/10 SUPPL-17(补充) Approval Labeling STANDARD
2023/07/10 SUPPL-15(补充) Approval Labeling STANDARD
2023/07/10 SUPPL-14(补充) Approval Labeling STANDARD
2023/07/10 SUPPL-13(补充) Approval Labeling STANDARD
2012/12/11 SUPPL-11(补充) Approval Labeling STANDARD
2012/07/18 SUPPL-9(补充) Approval Labeling STANDARD
2012/03/30 SUPPL-8(补充) Approval Labeling
2012/03/30 SUPPL-7(补充) Approval Labeling
2012/02/13 SUPPL-4(补充) Approval Manufacturing (CMC)
2010/08/20 SUPPL-5(补充) Approval Labeling
2009/03/04 SUPPL-3(补充) Approval Labeling
2008/06/30 SUPPL-2(补充) Approval Labeling
2006/05/08 SUPPL-1(补充) Approval Labeling
2005/05/31 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CLARITHROMYCIN 剂型/给药途径:TABLET;ORAL 规格:250MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
065155 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG Discontinued No No AB 2005/05/31 TEVA
065144 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG Prescription No No AB 2005/10/18 SANDOZ
065384 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG Prescription No No AB 2007/08/20 CHARTWELL
065489 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG Prescription No Yes AB 2012/07/25 AUROBINDO
202710 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG Prescription No No AB 2013/06/10 ESJAY PHARMA
203584 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG Prescription No No AB 2015/09/28 HEC PHARM
210459 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 250MG Prescription No No AB 2022/01/31 ALEMBIC
活性成分:CLARITHROMYCIN 剂型/给药途径:TABLET;ORAL 规格:500MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
065155 002 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG Discontinued No No AB 2005/05/31 TEVA
065136 001 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG Prescription No No AB 2005/08/25 SANDOZ
065384 002 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG Prescription No No AB 2007/08/20 CHARTWELL
065489 002 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG Prescription No Yes AB 2012/07/25 AUROBINDO
202710 002 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG Prescription No No AB 2013/06/10 ESJAY PHARMA
203584 002 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG Prescription No No AB 2015/09/28 HEC PHARM
210459 002 ANDA CLARITHROMYCIN CLARITHROMYCIN TABLET;ORAL 500MG Prescription No No AB 2022/01/31 ALEMBIC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database